Hypertension

This page includes news and new technology on hypertension. The condition is caused by abnormally high blood pressure that causes excess force and pressure of the blood against the artery walls. Long-term, this can cause damage the vessels and contributes to heart disease. Therapies include antihypertensive medications such as diurestics  and renal denervation therapy. 

News | September 09, 2013
September 9, 2013 -- Among patients with prehypertension and coronary artery disease, use of the renin (an enzyme...
Feature | September 03, 2013
September 3, 2013 — St. Jude Medical Inc. announced the CE mark approval of its next-generation EnligHTN renal...
News | August 22, 2013
August 22, 2013 — Qinghui Chen, assistant professor in Michigan Tech’s kinesiology and integrative physiology...
News | August 02, 2013
August 2, 2013 — Mercator MedSystems has been issued U.S. Patent 8,465,752, which protects the company’s sole U.S....
MEDTRONIC, symplicity renal denervation catheter

The Medtronic Symplicity catheter was the first renal denervation system to prove in clinical trials the therapy can lower drug-resistant hypertension.

Feature | July 30, 2013 | Dave Fornell
One of the exciting new frontiers for interventional cardiology is the use of renal denervation therapy to treat...
FDA US device innovation

The delay in being able to bring new medical device advances to market in the United States, such as transcatheter aortic valves and left atrial appendage occluders, has raised the question of the U.S. leadership role in technology innovation.

Feature | July 03, 2013 | Anita Asgar, M.D., FSCAI
The field of interventional cardiology is one of constant change and innovation. The past 10 years have documented...
News | June 13, 2013
June 13, 2013 — St. Jude Medical Inc. announced U.S. Food and Drug Administration (FDA) approval to begin the EnligHTN...
Boston Scientific Vessix Renal Denervation System Hypertension Therapies
News | June 06, 2013
June 6, 2013 — Boston Scientific Corporation reported interim data from the REDUCE-HTN clinical program, which...
News | June 03, 2013
June 3, 2013 — St. Jude Medical Inc. announced that the company’s EnligHTN multi-electrode renal denervation system ...
News | May 30, 2013
May 30, 2013 — Kona Medical announced three and six month results from the WAVE I study, a first-in-man study...
News | May 17, 2013
May 17, 2013 — Can high blood pressure be safely reduced and controlled by “disconnecting” nerves in the kidneys? That...
Feature | May 17, 2013
May 17, 2013 — Prof. Dr. Béla Merkely and Dr. Péter Sótonyi at Semmelweis Egyetem Kardiológiai Központ in Hungary...
News | April 24, 2013
April 24, 2013 — Cardiosonic Inc. announced the completion of the first phase of patient enrollment in its first-in-man...
News | April 12, 2013
April 12, 2013 — A research study of more than 600 black patients with uncontrolled hypertension found that less than...
Feature | April 01, 2013
April 1, 2013 — Rox Medical announced enrollment of the first U.K. patients in the CONTROL-HTN international randomized...